Cell and Tissue Imaging by TOF-SIMS and MALDI-TOF: An Overview for Biological and Pharmaceutical Analysis
- PMID: 34809729
- DOI: 10.1017/S1431927621013593
Cell and Tissue Imaging by TOF-SIMS and MALDI-TOF: An Overview for Biological and Pharmaceutical Analysis
Abstract
The potential of mass spectrometry imaging (MSI) has been demonstrated in cell and tissue research since 1970. MSI can reveal the spatial distribution of a wide range of atomic and molecular ions detected from biological sample surfaces, it is a powerful and valuable technique used to monitor and detect diverse chemical and biological compounds, such as drugs, lipids, proteins, and DNA. MSI techniques, notably matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) and time of flight secondary ion mass spectrometry (TOF-SIMS), witnessed a dramatic upsurge in studying and investigating biological samples especially, cells and tissue sections. This advancement is attributed to the submicron lateral resolution, the high sensitivity, the good precision, and the accurate chemical specificity, which make these techniques suitable for decoding and understanding complex mechanisms of certain diseases, as well as monitoring the spatial distribution of specific elements, and compounds. While the application of both techniques for the analysis of cells and tissues is thoroughly discussed, a briefing of MALDI-TOF and TOF-SIMS basis and the adequate sampling before analysis are briefly covered. The importance of MALDI-TOF and TOF-SIMS as diagnostic tools and robust analytical techniques in the medicinal, pharmaceutical, and toxicology fields is highlighted through representative published studies.
Keywords: MALDI-TOF; MSI; TOF-SIMS; biological species; drugs.
Similar articles
-
Changes in the molecular ion yield and fragmentation of peptides under various primary ions in ToF-SIMS and matrix-enhanced ToF-SIMS.Biointerphases. 2016 Jun 1;11(2):02A318. doi: 10.1116/1.4940911. Biointerphases. 2016. PMID: 26829968
-
Correlative mass spectrometry imaging, applying time-of-flight secondary ion mass spectrometry and atmospheric pressure matrix-assisted laser desorption/ionization to a single tissue section.Rapid Commun Mass Spectrom. 2018 Jan 30;32(2):159-166. doi: 10.1002/rcm.8022. Rapid Commun Mass Spectrom. 2018. PMID: 29105220 Free PMC article.
-
Intact lipid imaging of mouse brain samples: MALDI, nanoparticle-laser desorption ionization, and 40 keV argon cluster secondary ion mass spectrometry.Anal Bioanal Chem. 2016 Sep;408(24):6857-68. doi: 10.1007/s00216-016-9812-5. Epub 2016 Aug 22. Anal Bioanal Chem. 2016. PMID: 27549796 Free PMC article.
-
Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development.AAPS J. 2010 Mar;12(1):11-26. doi: 10.1208/s12248-009-9158-4. Epub 2009 Nov 17. AAPS J. 2010. PMID: 19921438 Free PMC article. Review.
-
Molecular mass spectrometry imaging in biomedical and life science research.Histochem Cell Biol. 2010 Nov;134(5):423-43. doi: 10.1007/s00418-010-0753-3. Epub 2010 Oct 28. Histochem Cell Biol. 2010. PMID: 20981554 Review.
Cited by
-
Development of a Laser Microdissection-Coupled Quantitative Shotgun Lipidomic Method to Uncover Spatial Heterogeneity.Cells. 2023 Jan 28;12(3):428. doi: 10.3390/cells12030428. Cells. 2023. PMID: 36766770 Free PMC article.
-
Identifying Process Differences with ToF-SIMS: An MVA Decomposition Strategy.J Am Soc Mass Spectrom. 2024 Dec 4;35(12):3116-3125. doi: 10.1021/jasms.4c00327. Epub 2024 Oct 4. J Am Soc Mass Spectrom. 2024. PMID: 39366671 Free PMC article.
-
Visualization of Nanocarriers and Drugs in Cells and Tissue.Handb Exp Pharmacol. 2024;284:153-189. doi: 10.1007/164_2023_684. Handb Exp Pharmacol. 2024. PMID: 37566121
-
Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2021-2022.Mass Spectrom Rev. 2025 May-Jun;44(3):213-453. doi: 10.1002/mas.21873. Epub 2024 Jun 24. Mass Spectrom Rev. 2025. PMID: 38925550 Free PMC article. Review.
-
Applications of spatially resolved omics in the field of endocrine tumors.Front Endocrinol (Lausanne). 2023 Jan 10;13:993081. doi: 10.3389/fendo.2022.993081. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36704039 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources